@article{d967b59bf7e14be4b812d8c0a7e36cd4,
title = "Langerhans Cells Prevent Autoimmunity via Expansion of Keratinocyte Antigen-Specific Regulatory T Cells",
abstract = "Langerhans cells (LCs) are antigen-presenting cells in the epidermis whose roles in antigen-specific immune regulation remain incompletely understood. Desmoglein 3 (Dsg3) is a keratinocyte cell-cell adhesion molecule critical for epidermal integrity and an autoantigen in the autoimmune blistering disease pemphigus. Although antibody-mediated disease mechanisms in pemphigus are extensively characterized, the T cell aspect of this autoimmune disease still remains poorly understood. Herein, we utilized a mouse model of CD4+ T cell-mediated autoimmunity against Dsg3 to show that acquisition of Dsg3 and subsequent presentation to T cells by LCs depended on the C-type lectin langerin. The lack of LCs led to enhanced autoimmunity with impaired Dsg3-specific regulatory T cell expansion. LCs expressed the IL-2 receptor complex and the disruption of IL-2 signaling in LCs attenuated LC-mediated regulatory T cell expansion in vitro, demonstrating that direct IL-2 signaling shapes LC function. These data establish that LCs mediate peripheral tolerance against an epidermal autoantigen and point to langerin and IL-2 signaling pathways as attractive targets for achieving tolerogenic responses particularly in autoimmune blistering diseases such as pemphigus.",
keywords = "Autoimmune disease, Langerhans cells, Pemphigus, Regulatory T cells",
author = "Kitashima, {Daniela Y.} and Tetsuro Kobayashi and Therese Woodring and Kacey Idouchi and Thomas Doebel and Benjamin Voisin and Takeya Adachi and Takeshi Ouchi and Hayato Takahashi and Koji Nishifuji and Kaplan, {Daniel H.} and Clausen, {Bj{\"o}rn E.} and Masayuki Amagai and Keisuke Nagao",
note = "Funding Information: This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan ( 24390277 for K.Na. and 21229014 for M.A.), Research on Measures against Intractable Diseases , the Ministry of Health, Labour and Welfare of Japan ( 14427215 ) and the Intramural Research Program, Center for Cancer Research, National Cancer Institute, National Institute of Health ( ZIA BC 011561 ). D.Y.K. received a scholarship from the Ministry of Education, Culture, Sports, Science and Technology. T.K. is a JSPS-NIH fellow. T. W. was funded by the NIH Medical Research Scholars Program, supported jointly by the NIH and contributions to the Foundation for the NIH from the Doris Duke Charitable Foundation, the American Association for Dental Research, the Colgate-Palmolive Company, Genentech, and other private donors. Funding Information: This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (24390277 for K.Na. and 21229014 for M.A.), Research on Measures against Intractable Diseases, the Ministry of Health, Labour and Welfare of Japan (14427215) and the Intramural Research Program, Center for Cancer Research, National Cancer Institute, National Institute of Health (ZIA BC 011561). D.Y.K. received a scholarship from the Ministry of Education, Culture, Sports, Science and Technology. T.K. is a JSPS-NIH fellow. T. W. was funded by the NIH Medical Research Scholars Program, supported jointly by the NIH and contributions to the Foundation for the NIH from the Doris Duke Charitable Foundation, the American Association for Dental Research, the Colgate-Palmolive Company, Genentech, and other private donors. Publisher Copyright: {\textcopyright} 2017",
year = "2018",
month = jan,
doi = "10.1016/j.ebiom.2017.12.022",
language = "English",
volume = "27",
pages = "293--303",
journal = "EBioMedicine",
issn = "2352-3964",
publisher = "Elsevier BV",
}